calendar
11 catalysts · 2 phase iv trial initiation · 2 phase 2 completion · 2 phase 2 initiation · 1 phase 1 initiation · 1 phase 3 completion · 1 drug expiry
next 91 dayslessmore
MonWedFri
11 catalysts · 2 phase iv trial initiation · 2 phase 2 completion · 2 phase 2 initiation · 1 phase 1 initiation · 1 phase 3 completion · 1 drug expiry
Therapy area: Infectious Disease, Respiratory. Indication: Asthma, Influenzavirus A Infections, Influenzavirus B Infections
Therapy area: Infectious Disease, Respiratory. Indication: Asthma, Influenzavirus A Infections, Influenzavirus B Infections
Therapy area: Dermatology, Immunology. Indication: Atopic Dermatitis (Atopic Eczema), Plaque Psoriasis (Psoriasis Vulgaris), Systemic Lupus Erythematosus
Therapy area: Dermatology. Indication: Androgenic Alopecia
Therapy area: Dermatology. Indication: Wounds
Therapy area: Dermatology. Indication: Androgenic Alopecia
Therapy area: Respiratory. Indication: Chronic Obstructive Pulmonary Disease (COPD)
Therapy area: Ophthalmology. Indication: Keratoconjunctivitis Sicca (Dry Eye), Unspecified Ophthalmological Disorders
Therapy area: Ophthalmology. Indication: Age Related Macular Degeneration, Macular Degeneration, Wet (Neovascular / Exudative) Macular Degeneration
Therapy area: Respiratory. Indication: Asthma
Therapy area: Dermatology. Indication: Androgenic Alopecia